Browsing Tag
Odeon Capital Group
2 posts
Can Irenic Acquisition turn a $220m blank-check IPO into an aerospace deal winner?
Irenic’s $220M SPAC puts activist capital into aerospace and defense. See why target selection may decide the real upside.
April 28, 2026
VERAXA Biotech clears final shareholder hurdle as Voyager Acquisition votes yes on $1.35bn oncology de-SPAC
Voyager Acquisition shareholders approve VERAXA Biotech combination. The cancer ADC and TCE platform heads to NASDAQ as VRXA. Read the full analysis.
March 14, 2026